Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 603 across all filing types
Latest filing 2023-01-16 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The content focuses on share repurchase activity and changes in issued shares, with no financial statements or earnings data. This matches the description of a report on the company's transactions in its own shares (share buybacks). Therefore, the document is best classified as a 'Transaction in Own Shares' (POS) filing.
2023-01-16 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about share repurchases, fitting the category of Transaction in Own Shares (POS). The document length and detail confirm it is the report itself, not just an announcement.
2023-01-13 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, confirming compliance with listing rules of the Stock Exchange of Hong Kong (SEHK). The content focuses on share repurchase transactions, quantities, prices, and confirmations by company officers. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about share repurchases, fitting the category of Transaction in Own Shares (POS). The document length (11,449 characters) supports it being a full disclosure rather than a brief announcement. Therefore, the classification is POS with high confidence.
2023-01-12 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, confirming compliance with listing rules and providing specifics on share repurchase transactions. The content focuses on reporting share repurchase activity rather than announcing a new share issue or capital change. This fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document is substantive and detailed, not merely an announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-01-11 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements or comprehensive financial performance data, nor is this a report or presentation. It is a regulatory disclosure about share repurchases, fitting the category of Transaction in Own Shares (POS). The document length is over 11,000 characters, indicating it is a substantive disclosure rather than a brief announcement or certification.
2023-01-10 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It details repurchases of shares on specific dates, quantities, prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements or comprehensive financial performance data, nor is it an announcement of a report publication. The document is a regulatory disclosure about share repurchases, fitting the category of Transaction in Own Shares (POS).
2023-01-09 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.